Clinical trial
Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate…
NCT00273364 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00273364 |
|---|---|
| Title | Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study |
| Official title | Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Uppsala University Sheffield Teaching Hospitals NHS Foundation Trust University of Sao Paulo |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | Hematopoietic Stem Cell Therapy, Standard treatment with a conventional drug |
| Enrollment | 110 |
| Start date | Nov 16, 2005 |
| Primary completion | Jan 5, 2017 |
| Completion | Aug 30, 2019 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 12, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: